Prot #CO-338-100: LODESTAR: A Phase 2 MuLticenter, Open-label Study of Rucaparib as Treatment for SoliD Tumors Associated with DEleteriouS MuTations in Homologous RecombinAtion Repair Genes

Project: Research project

Project Details

StatusActive
Effective start/end date8/10/208/10/23

Funding

  • PSI Pharma Support America Inc. (Prot #CO-338-100)
  • Clovis Oncology, Inc. (Prot #CO-338-100)